Interleukin-6 leads to interleukin-10 production in several human multiple myeloma cell lines. Does interleukin-10 enhance the proliferation of these cells?

Leukemia Research

Volumn 34, Issue 7, 2010, Pages 912-916

  Kovacs, Eva ^a  

^a NONE   (Switzerland)

Author keywords

Gp130; IL 10; IL 6; Multiple myeloma; Proliferation; Receptors

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; INTERLEUKIN 6 RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; CELL GROWTH; CELL LINE; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; MYELOMA CELL; PRIORITY JOURNAL; REGULATORY MECHANISM; UPREGULATION;

ASCITES; BONE MARROW; CELL DIVISION; CELL LINE, TUMOR; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; LYMPH NODES; MULTIPLE MYELOMA; NEOPLASM PROTEINS; PARACRINE COMMUNICATION; PLEURA; RECEPTORS, INTERLEUKIN-6; RECOMBINANT PROTEINS;

EID: 77952950744     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2009.08.012     Document Type: Article

References (16)

1. Lauta V.M. A review of the cytokine network in multiple myeloma diagnostic, prognostic, and therapeutic implications. Cancer 2003, 97:2440-2452.
2. Urbanska-Rys H., Wiersbowska A., Stepien H., Robak T. Relationship between circulating interleukin-10 (IL-10) with interleukin-6 (IL-6) type cytokines (IL-6, interleukin-11 (IL-11), oncostatin M (OSM) and soluble interleukin-6 (IL-6) receptor (sIL-6R) in patients with multiple myeloma. Eur Cytokine Netw 2000, 11:443-451.
3. Kovacs E. How does interleukin-6 affect the membrane expressions of interleukin-6 receptor and gp130 and the proliferation of the human myeloma cell line OPM-2?. Biomed Pharmacother 2003, 57:489-494.
4. Kovacs E. Multiple myeloma and B cell lymphoma. Investigation of IL-6, IL-6 receptor antagonist (IL-6RA) and gp130 antagonist (gp130A) using various parameters in an vitro model. Scientific World J 2006, 6:888-898.
5. Klein B., Zhang X.G., Jourdan M., Content J., Houssiau F., Aarden L., et al. Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood 1989, 73:517-526.
6. Otsuki T., Yamada O., Yata K., Sakaguchi H., Kurebayashi J., Yawata Y., et al. Expression and production of interleukin 10 in human myeloma cell lines. Br J Haematol 2000, 111:835-842.
7. Klein B., Lu Z.Y., Costes V., Jourdan M., Rossi J.F. Interleukin-10 and Gp130 cytokines in human multiple myeloma. Leuk Lymphoma 1999, 34:63-70.
8. Otsuki T., Yata K., Sakaguchi H., Uno M., Fujii T., Wada H., et al. IL-10 in myeloma cells. Leuk Lymphoma 2002, 43(5):969-974.
9. Lu Z.Y., Zhang X.G., Rodriguez C., Wijdenes J., Gu Z.J., Morel-Fournier B., et al. Interleukin-10 is a proliferation factor but not a differentiation factor for human myeloma cells. Blood 1995, 85:2521-2527.
10. Masood R., Zhang Y., Bond M.W., Scadden D.T., Moudgil T., Law R.E., et al. Interleukin-10 is an autocrine growth factor for acquired immunodeficiency syndrome-related B-cell lymphoma. Blood 1995, 85:3423-3430.
11. Jones K.D., Aoki Y., Chang Y., Moore P.S., Yarchoan R., Tosato G. Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi's sarcoma herpesvirus-associated infected primary effusion lymphoma cells. Blood 1999, 94:2871-2879.
12. Voorzanger N., Touitou R., Garcia E., Delecluse H.J., Rousset F., Joab J., et al. Interleukin (IL)-10 and IL-6 are produced in vivo by non-Hodgkin's lymphoma cells and act as cooperative growth factors. Cancer Res 1996, 56:5499-5505.
13. Pappa C., Miyakis S., Tsirakis, Sfiridaki A., Alegakis A., Kafousi M., et al. Serum levels of interleukin-15 and interleukin-10 and their correlation with proliferating cell nuclear antigen in multiple myeloma. Cytokine 2007, 37:171-175.
14. Kovacs E., Link S., Toffol-Schmidt U. The cytostatic and cytocid effect of Viscum album extract. Drug Res 2006, 56:467-473.
15. Huang Y.W., Vitetta E.S. Immunotherapy of multiple myeloma. Stem Cells 1995, 13:123-134.
16. Campo S., Serlupi-Crescenzi O., Arseni B., Rossi S., Saggio I., Salone B., et al. Comparative activity of Sant 7 and anti-IL-6, IL-6 monoclonal antibodies in a murine model of B cell lymphoma. Cytokine 2005, 31:368-374.